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Abstract: The 5-HT
3
receptor is one of several ion channels responsible for the transmission of nerve impulses
in the peripheral and central nervous systems. Until now, it has been difficult to characterize transmembrane
receptors with classical structural biology approaches like X-ray crystallography. The use of photoaffinity probes
is an alternative approach to identify regions in the protein where small molecules bind. To this end, we present
two photoaffinity probes based on granisetron, a well known antagonist of the 5-HT
3
receptor. These new probes
show nanomolar binding affinity for the orthosteric binding site. In addition, we investigated their reactivity using
irradiation experiments.
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Introduction
In popular science serotonin is referred
as a ‘happiness hormone’. Also known as
5-hydroxytryptamine (5-HT), it is an im-
portant neurotransmitter that is involved in
many processes in the human body such
as the regulation of appetite, mood, sleep,
vasoconstriction, body temperature and
gastrointestinal motility. It may also be as-
sociated with disorders such as aggression,
anxiety, addiction, emesis and nausea.
[1]
The family of human serotonin recep-
tors contains seven different subtypes (5-
HT
1
to 5-HT
7
) that are widely distributed
throughout the body.
[2]
Most serotonin
receptors are G-protein coupled receptors
that influence the intracellular concentra-
tions of cAMP and IP3.
[3]
The only excep-
tion is the 5-HT
3
receptor, a ligand-gated
ion channel selective for sodium and po-
tassium ions. They are transmembrane
proteins, composed of five subunits that
surround an ion-conducting pore and their
activation triggers a neuronal excitation
by depolarization of the cell plasma mem-
brane (Fig. 1).
[4]
There are several approved drugs that
selectively antagonize 5-HT
3
receptors and
these are primarily used to treat chemo-
therapy-, radiotherapy- and post operative-
induced nausea and vomiting.
Binding of serotonin triggers the open-
ing of an ion channel, but competitive an-
tagonists like granisetron are able to block
the orthosteric binding site and thereby in-
hibit pore opening. Until now, a high-reso-
lution crystal structure of the 5-HT
3
recep-
tor has not been obtained and our knowl-
edge of the binding cavity has largely been
based on mutagenesis and homology with
related proteins.
[5]
The aim of our project is the develop-
ment of photoaffinity probes that can be
used to covalently modify the 5-HT
3
recep-
tor, and after subsequent enzymatic diges-
tion, identify the orientation of the ligand
in the binding pocket by mass spectrom-
etry (Scheme 1).
We base our probe design on the
known high-affinity ligand granisetron.
[6]
Previous studies in our group have iden-
tified three positions where bulky groups
can be introduced to the molecule without
losing the binding affinity of the parent
compound (Fig. 2).
[7]
Synthesis of Photolabile
Antagonists
Based on the structure–activity rela-
tionship studies of granisetron we intro-
duced a photolabile diazirine at the inda-
zole position N(1) and C(7) to obtain two
final compounds 1 and 2, which were syn-
thesized according to the procedure shown
in Schemes 2–5.
The compounds 1 and 2 were assem-
Fig. 1. Homology
model of the 5-HT
3
receptor based on a
related GLIC struc-
ture (PDB ID: 3EAM)
showing the side view
(A) and top view (B).
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butyl lithium and diethyl-trifluoro-acet-
amide yielded the ketone 17, which was
transformed to the tosylated oxime 18.
The activated oxime 18 then reacted with
liquid ammonia to yield the correspond-
ing diaziridine which was oxidized with
manganese dioxide to the corresponding
diazirine 19. This was followed by alcohol
deprotection to obtain 20 and subsequent-
ly by oxidization to give diazirine acid 21
(Scheme 6).
In the final reaction the granisetron
derivatives 13 and 14 were coupled with
the photolabile diazirine 21 to give the two
photoaffinity probes 1 and 2 (Scheme 5).
Binding Affinity
We explored the binding properties of
the two compounds 1 and 2 at the 5-HT
3
receptor by competition with radiolabeled
[
3
H]granisetron. Both compounds had
binding affinities in the nanomolar range,
with compound 2 showing the comparably
higher affinity, with aK
i
of 8 nM compared
to 1 with a K
i
of 123 nM.
bled using a convergent synthetic strategy
based on the bicyclic amine 5, an indazole
core 8/9 and an aromatic diazirine acid 21.
The bicyclic amine 5 was synthesized ac-
cording to literature protocols (Scheme
2),
[8]
starting from glutaraldehyde and
aceton-1,3-dicarboxylic acid, which forms
pseudopelletierine (3) in a Robinson tropi-
non-type synthesis.
[9]
In this double-Man-
nich-decarboxylation cascade reaction bi-
cyclic product 3 is produced in high yields
(95%). The keto group was then converted
to the hydroxylamine 4 which could be re-
duced with AlH
3
that was formed in situ
from LiAlH
4
and H
2
SO
4
, to yield endo-
amine 5 as a single isomer.
Primary amine 5 was coupled either
to commercially available 1H-indazole-
3-carboxylic acid 9 (Scheme 3), which
allows the modification on the N(1) po-
sition, or was coupled to 7-methoxy-1H-
indazole-3-carboxylic acid (8), which was
synthesized according to the literature,
starting from 3-methoxyphenol as shown
in Scheme 4.
[10]
After the introduction of a TMS group
and conversion of the OTMS group to a
better leaving group (OTf) the indazole
core was formed by a 1,3-dipolar cyclo-
addition of in situ generated benzyne and
ethyl diazoacetate. The subsequent saponi-
fication led to 8, which could be coupled
with bicyclic amine 5, to yield 10. The in-
dazole nitrogen N(1) of compound 10 was
methylated and the methoxygroup cleaved
in the second step to allow further func-
tionalization with linkers and the photoac-
tivatable diazirine.
3-(N-Boc-amino)propyl bromide was
used as a linker which was attached via the
hydroxy group of 12, or via the indazole
nitrogen N(1) in the case of 11.
The subsequent deprotection gave
the amines 13 and 14 (Scheme 5) which
allowed the introduction of the photola-
bile diazirine group that was synthesized
as shown in Scheme 6.
[11]
Treating TBS-
protected 4-bromo-phenylmethanol with
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Scheme 3. Reagents
and conditions: (a)
HOBt, DCC, CH
2
Cl
2
,
14 h, r.t., 82% (8),
quant. (9); (b) KOt-Bu,
MeI, THF/DMF, 42%;
(c) BBr
3
, CH
2
Cl
2
, 24 h,
r.t., crude.
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Fig. 2. Granisetron can be modified at the ni-
trogens N(1) and N(9’) as well as C(7).
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Scheme 2. Reagents and conditions: (a)
MeNH
3
Cl, Na
2
HPO
4
, NaOH, 20 h, r.t.; (b) HCl,
1 h, 100 °C, for both steps: 95%; (c) NaOAc,
NH
3
OHCl, 4 h, r.t. 92%; (d) H
2
SO
4
, LiAlH
4
, THF,
8 h, r.t. to 45 °C, 30–92%.
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Scheme 4. Reagents and conditions: (a) HMDS
1 h, 75 °C, crude; (b) i-Pr
2
NH, n-BuLi, TMS-
Cl, THF, 13 h, –78 °C to r.t., 87%; (c) n-BuLi,
Tf
2
O, Et
2
O, 0 °C to r.t., 90%; (d) N
2
CHCO
2
Et,
TBAF, THF, –78 °C to r.t., 24 h, 81%; (e) NaOH,
MeOH, 14 h, 60 °C, quant.
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To verify the stability of diazirines in
lab light conditions we exposed 3-(4-(bro-
momethyl)phenyl)-3-(trifluoromethyl)-
3H-diazirine to lab light and followed its
decomposition with
19
F-NMR. First pho-
to-decomposition (16%) peaks similar to
compounds 22 and 23 were detected after
6.5 h and full conversion of the diazirine
was observed after 76 h. This low reactiv-
ity allows the handling of diazirine com-
pounds without excessive light protection.
Conclusion
We have successfully synthesized two
new photoaffinity probes based on the se-
lective and high-affinity 5-HT
3
receptor
antagonist granisetron. The probes were
tested at the human 5-HT
3
receptor and
revealed nanomolar binding. The probes
were irradiated to investigate reaction times
In previous studies we showed that a
bulky fluorophore attached to the inda-
zole nitrogen of granisetron was tolerated
without losing the binding affinity.
[7]
As
compounds 1 and 2 contained two identi-
cal linker/diazirine combinations at C(7)
and N(1), their binding affinities can be
directly compared. The data suggest that
the granisetron binding pocket is less ste-
rically confined around the N(1) nitrogen
and thus this position is more likely to ac-
commodate bulky modifications.
[12]
Irradiation of Diazirines
Diazirines are known to form a carbene
by extruding N
2
when irradiated with low-
energy wavelength light (>300 nm).
[13]
These long wavelengths and the ability of
the newly formed highly reactive carbene
to rapidly insert into C–H or heteroatom–
H bonds, allows their use to covalently
modify proteins.
[14]
First, we investigated the stability of
our compounds in daylight conditions
and their behavior under UV irradia-
tion (365/302 nm) by dissolving them in
deuterated methanol and measuring the
19
F-NMR signal intensity at different ir-
radiation times. We observed the forma-
tion of several products and identified two
main compounds by MS, similar to those
described by Hosoya and coworkers (Fig.
3).
[15]
One was the insertion product 23
of the carbene into the D–O bond of d
4
-
MeOD, and the second was the isomerized
diazo compound 22 shown in Scheme 7.
We further found that irradiating the
sample with shorter wavelength light (302
nm) produced more insertion product 23
from 22, presumably through the interme-
diacy of the carbene. This is in agreement
with similar published studies.
[15]
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Scheme 6. Reagents and conditions: (a) TBS-
Cl, imidazole, DMF, 14 h, 40 °C, quant.; (b)
n-BuLi, diethyl-trifluoro-acetamide, Et
2
O, 4 h,
–78 °C, 78%; (c) hydroxylamine HCl, Pyridine,
EtOH, 4 h, 60 °C, crude; (d) TsCl, Pyridine, 3.5
h, both steps: 59%; (e) NH
3
, Et
2
O, 14 h, –78 °C
to r.t., 90%; (f) MnO
2
, CH
2
Cl
2
, 48 h, r.t. 70%;
(g) HCl, MeOH 6 h, r.t., 53%; (h) KMnO
4
, KOH,
dioxane, 2 h, r.t., 70%.
Fig. 3. a)
19
F-NMR of irradiated diazirine 1 (–66.9 ppm) (irradiation: 8 min at 365 nm, then 17.5 min at 302 nm) b)
19
F-NMR signal ratio of compound 1
to the two main decomposition products over irradiation time.
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Scheme 5. (a) KOt-
Bu, 3-(N-boc-amino)
propylbromide, THF/
DMF, 14 h, 0 °C to r.t.;
(b) HCl, dioxane, 14
h, r.t., for both steps:
70% (13), 31% (14);
(c) HATU, Et
3
N, 24%
(2), 20% (1).
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for further experiments in receptor labeling
and showed a high reactivity at long wave-
length irradiation. This makes them useful
tools for investigating the 5-HT
3
recep-
tor binding site, by photocrosslinking the
probes with the receptor and subsequent
digestion. The resulting fragments will
be analyzed by mass spectrometry and, in
conjunction with homology models and
mutagenesis data, will help to identify
the position and orientation of the probes
in the receptor binding pocket. These ex-
periments are part of our ongoing efforts
to develop fluorescent and bioorthogonal
molecular tools for the investigation of
transmembrane proteins, including ligand-
gated ion channels (hERG), G-protein
coupled receptors (adenosine receptors)
and transporters (high-affinity glutamate
transporters and TRPV channels).
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